These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20937783)

  • 1. High levels and safety of oseltamivir carboxylate plasma concentrations after nasogastric administration in critically ill children in a pediatric intensive care unit.
    Giraud C; Manceau S; Oualha M; Chappuy H; Mogenet A; Duchêne P; Ducrocq S; Hubert P; Treluyer JM
    Antimicrob Agents Chemother; 2011 Jan; 55(1):433-5. PubMed ID: 20937783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.
    Eyler RF; Heung M; Pleva M; Sowinski KM; Park PK; Napolitano LM; Mueller BA
    Pharmacotherapy; 2012 Dec; 32(12):1061-9. PubMed ID: 23208833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies.
    Muñoz FM; Anderson EJ; Deville JG; Clinch B; Kamal MA
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):531-40. PubMed ID: 26042486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
    Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
    Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza.
    Ariano RE; Sitar DS; Zelenitsky SA; Zarychanski R; Pisipati A; Ahern S; Kanji S; Rello J; Kumar A
    CMAJ; 2010 Mar; 182(4):357-63. PubMed ID: 20159892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Route of Oseltamivir Administration Affects Metabolite Concentrations in Critically Ill Children.
    Tang Girdwood SC; Mizuno T; Krallman KA; Benken LA; Stoneman EM; Yunger TM; Wong HR; Vinks AA; Kaplan JM
    Pediatr Infect Dis J; 2019 Dec; 38(12):1224-1227. PubMed ID: 31738337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support.
    Wildschut ED; de Hoog M; Ahsman MJ; Tibboel D; Osterhaus AD; Fraaij PL
    PLoS One; 2010 Jun; 5(6):e10938. PubMed ID: 20532176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza.
    Lemaitre F; Luyt CE; Roullet-Renoleau F; Nieszkowska A; Zahr N; Corvol E; Fernandez C; Antignac M; Farinotti R; Combes A
    Ther Drug Monit; 2012 Apr; 34(2):171-5. PubMed ID: 22354159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
    Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R
    Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
    Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
    Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique.
    Kromdijk W; Sikma MA; van den Broek MP; Beijnen JH; Huitema AD; de Lange DW
    Intensive Care Med; 2013 May; 39(5):977-8. PubMed ID: 23443310
    [No Abstract]   [Full Text] [Related]  

  • 12. A part-randomized study of intravenous oseltamivir in adolescents and adults.
    Várkonyi I; Chappey C; Giraudon M; Burleigh L
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1181-8. PubMed ID: 25678009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of oseltamivir during the 2009 influenza pandemic.
    Donner B; Bader-Weder S; Schwarz R; Peng MM; Smith JR; Niranjan V
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):532-43. PubMed ID: 21448900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critically ill children with pandemic influenza (H1N1) in pediatric intensive care units in Turkey.
    Kendirli T; Demirkol D; Yildizdas D; Anil AB; Asilioğlu N; Karapinar B; Erkek N; Sevketoğlu E; Dursun O; Arslanköylü AE; Bayrakçi B; Bosnak M; Köroğlu T; Horoz OO; Citak A; Kesici S; Ates C; Karaböcüoğlu M; Ince E
    Pediatr Crit Care Med; 2012 Jan; 13(1):e11-7. PubMed ID: 21263368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
    Taylor WR; Thinh BN; Anh GT; Horby P; Wertheim H; Lindegardh N; de Jong MD; Stepniewska K; Hanh TT; Hien ND; Bien NM; Chau NQ; Fox A; Ngoc NM; Crusat M; Farrar JJ; White NJ; Ha NH; Lien TT; Trung NV; Day N; Binh NG
    PLoS One; 2008; 3(10):e3410. PubMed ID: 18923671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.
    Maltezou HC; Drakoulis N; Siahanidou T; Karalis V; Zervaki E; Dotsikas Y; Loukas YL; Theodoridou M
    Pediatr Infect Dis J; 2012 May; 31(5):527-9. PubMed ID: 22209917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital.
    Lera E; Wörner NT; Sancosmed M; Fàbregas A; Casquero A; Melendo S; Miserachs M; Tórtola T; Borrego A; Campins M; Moraga F; Figueras C; Cebrián R
    Eur J Pediatr; 2011 Mar; 170(3):371-8. PubMed ID: 21274563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2009 pandemic influenza A (H1N1) in critically ill children in Cincinnati, Ohio.
    Morgan CI; Hobson MJ; Seger B; Rice MA; Staat MA; Wheeler DS
    Pediatr Crit Care Med; 2012 May; 13(3):e140-4. PubMed ID: 21760562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oseltamivir pharmacokinetics and clinical experience in neonates and infants during an outbreak of H1N1 influenza A virus infection in a neonatal intensive care unit.
    Standing JF; Nika A; Tsagris V; Kapetanakis I; Maltezou HC; Kafetzis DA; Tsolia MN
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3833-40. PubMed ID: 22564835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza.
    Yoo JW; Choi SH; Huh JW; Lim CM; Koh Y; Hong SB
    J Med Virol; 2015 Oct; 87(10):1649-55. PubMed ID: 25946636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.